Unlock instant, AI-driven research and patent intelligence for your innovation.

VEGF (vascular endothelial growth factor) resistant protein composition and preparation method thereof

A harvested, chromatographic technology, applied in the field of anti-VEGF composition and its preparation, which can solve the problems of vision loss, submacular effusion and the like

Pending Publication Date: 2022-04-26
REGENERON PHARM INC
View PDF59 Cites 0 Cited by
  • Summary
  • Abstract
  • Description
  • Claims
  • Application Information

AI Technical Summary

Problems solved by technology

Leakage of the CNV can cause macular edema and fluid accumulation under the macula, which can lead to vision loss

Method used

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
View more

Image

Smart Image Click on the blue labels to locate them in the text.
Viewing Examples
Smart Image
  • VEGF (vascular endothelial growth factor) resistant protein composition and preparation method thereof
  • VEGF (vascular endothelial growth factor) resistant protein composition and preparation method thereof
  • VEGF (vascular endothelial growth factor) resistant protein composition and preparation method thereof

Examples

Experimental program
Comparison scheme
Effect test

preparation example Construction

[0323]As used herein, the term "protein" or "protein of interest" may include any polymer of amino acids having covalently attached amide bonds. Examples of target proteins include, but are not limited to, Aflibercept and MiniTrap. Proteins comprise one or more polymer chains of amino acids and are commonly referred to in the art as "polypeptides". "Polypeptide" means a polypeptide consisting of amino acid residues, related naturally occurring structural variants, and synthetic non-naturally occurring analogs thereof linked by peptide bonds, related naturally occurring structural variants, and synthetic non-naturally occurring analogs thereof composed of polymers. "Synthetic peptide or polypeptide" refers to a non-naturally occurring peptide or polypeptide. Synthetic peptides or polypeptides can be synthesized, for example, using an automated polypeptide synthesizer. Various solid phase peptide synthesis methods are known to those skilled in the art. A protein may contain ...

Embodiment 1

[0725] Example 1: Protein production using chemically defined media

[0726] 1.1 Cell source and harvest

[0727] Aflibercept-producing cell lines were used in this study. Aflibercept-producing cell lines were grown and harvested using chemically defined media (CDM).

[0728] 1.2 Proteolytic cleavage of aflibercept

[0729] With immobilized IdeS enzyme (obtained from Genovis (Cambridge, MA) ) column was used to generate MT1. Aflibercept (20 mg in 1.0 mL cleavage buffer) obtained from the cell culture harvest was added to the column and incubated at 18°C ​​for 30 minutes. After 30 minutes, the column was washed with cleavage buffer (1.0 mL). Combine the digestion mixture with the wash solution. The mixture was loaded on an analytical protein A affinity column (Applied Biosystems TM , POROS TM 20 μΜ Protein A cartridge 2.1 x 30 mm, 0.1 mL (Catalog No. 2-1001-00) was applied to and eluted from. According to POROS TM 20 μM Protein A Cartridge 2.1 x 30 mm, 0.1 mL (Catalo...

Embodiment 2

[0730] Example 2. Anion Exchange Chromatography (AEX) for Minimizing Color

[0731] (A) Reduce color formation using AEX

[0732] AEX chromatography was performed to remove the staining obtained during the production of aflibercept expressed with CDM1.

[0733] 2.1 Design

[0734] As detailed in Table 2-1, five AEX separations were performed for this study using the AEX protocol as described in Table 2-2. A 15.7mL Q Sepharose Fast Flow column (19.5cm bed height, 1.0cm I.D.) and a 14.1mL POROS 50 HQ column (18.0cm bed height, 1.0cm I.D.) were integrated into an AKTA Avant benchtop LC controller.

[0735]The pH of the AEX loading solution was adjusted to target ±0.05 pH units using 2M Tris base or 2M acetic acid. The conductivity of the AEX loading solution was adjusted to target ±0.1 mS / cm using 5M NaCl or deionized water. All pooled samples were analyzed for high molecular weight (HMW), color and yield.

[0736] Table 2-1. Overview of study design for AEX color reduction ...

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

PUM

PropertyMeasurementUnit
absorbanceaaaaaaaaaa
Login to View More

Abstract

The present disclosure relates to compositions comprising anti-VEGF proteins and methods for preparing such compositions.

Description

[0001] sequence listing [0002] This application contains a Sequence Listing, which has been filed electronically in ASCII format and is hereby incorporated by reference in its entirety. Said ASCII copy, created on August 13, 2020, is named 070816-02401_SL.txt and is 134,386 bytes in size. [0003] Cross References to Related Applications [0004] This application claims priority to and benefit of U.S. Provisional Patent Application No. 63 / 065,012, filed August 13, 2020, the contents of which are hereby incorporated by reference in their entirety. technical field [0005] The present invention generally relates to anti-VEGF compositions and methods for their preparation. Background technique [0006] Protein-based biopharmaceutical compositions have become important products for research, treatment of ophthalmic diseases, cancer, autoimmune diseases, infections, and other diseases and conditions. Biomedicine represents one of the fastest growing product areas in the phar...

Claims

the structure of the environmentally friendly knitted fabric provided by the present invention; figure 2 Flow chart of the yarn wrapping machine for environmentally friendly knitted fabrics and storage devices; image 3 Is the parameter map of the yarn covering machine
Login to View More

Application Information

Patent Timeline
no application Login to View More
Patent Type & Authority Applications(China)
IPC IPC(8): C07K19/00C07K1/22C07K1/20C07K1/18C07K1/16C12P21/06
CPCC07K2319/30C07K14/71C12N15/85C07K16/22C07K16/28C07K2317/622C07K2319/33A61P17/06A61P19/02A61P27/02A61P35/00C12N5/0018A61K38/179C12N5/0031C12P21/06C12Y304/21004C12P21/02C07K1/36G01N30/80G01N2030/027C07K1/16C07K1/113C12N2800/10C07K1/22C07K1/18A61K38/1866C12N2500/32C07K1/165C07K16/283C12N15/66C12N2510/02C07K1/20C12N2500/20C07K1/06C12N2529/10
Inventor A·塔斯蒂安A·瓦塔克T·大力E·彼莱斯N·帕拉卡尔王顺海李宁M·富兰克林
Owner REGENERON PHARM INC